The Community Health Center Drug Pricing Protection Act requires pharmaceutical manufacturers to provide Federally-qualified health centers (FQHCs) with the lowest 340B ceiling prices upfront at the point of purchase, rather than charging higher prices with rebates or reimbursements coming later. This legislation affects community health centers that serve low-income and uninsured patients across the country, ensuring they pay the full discounted price immediately when buying covered outpatient drugs instead of fronting higher costs. The bill takes effect immediately upon enactment and applies to all drug purchases made after the law passes, with the amendments also applying retroactively to existing manufacturer agreements to ensure compliance with the new requirement. No new federal funding is specified in the bill, as it primarily modifies existing pricing requirements under the 340B drug pricing program that already provides discounts to eligible health centers.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.